AGL agilon health, inc.
NYSE · SEC CIK 1831097 · EDGAR
- Bought, last 12 months
- $351.0K 5 purchases by 4 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 204 since 2021-07-16, latest 2026-08-18 17:44
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Shaker Benjamin | Chief Markets Off | $300.0K | — |
| Wulf John William | Dir | $51.0K | — |
| O'Rourke Timothy Patrick | CEO, Pres, Dir | — | — |
| Zamore Denise | CLO | — | — |
| Gertsch Timothy | CAO | — | — |
| Venkatachaliah Girish | CTO | — | — |
| Battaglia Silvana | Dir | — | — |
| MCKENZIE DIANA | Dir | — | — |
| McLoughlin Karen | Dir | — | — |
| Schwaneke Jeffrey A. | CFO | — | — |
Transactions 298
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2022-09-29 | 2022-04-14 | AGL | Desai Veeral | Chief Strategy, Dev. Off | F - Tax | $23.07 | -1,482 | 276.7K | -0.5% | -$34.2K |
| A | 2022-09-29 | 2022-04-14 | AGL | Kornitzer Benjamin | Chief Med, Quality Off | F - Tax | $23.07 | -427 | 10.4K | -4% | -$9,851 |
| DM | 2022-09-28 | 2022-09-26+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $22.86 | -16.2K | 10.9K | -60% | -$370.1K |
| DM | 2022-09-28 | 2022-09-26+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $4.49 | +16.2K | 21.6K | +297% | +$72.7K |
| DM | 2022-09-12 | 2022-09-08+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $22.82 | -21.6K | 10.9K | -67% | -$492.5K |
| DM | 2022-09-12 | 2022-09-08+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $4.49 | +21.6K | 24.3K | +782% | +$96.9K |
| DM | 2022-08-25 | 2022-08-23+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $20.70 | -10.8K | 10.9K | -50% | -$223.3K |
| DM | 2022-08-25 | 2022-08-23+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $4.49 | +10.8K | 16.2K | +198% | +$48.5K |
| I | 2022-08-12 | 2022-08-11 | AGL | CD&R Investment Associates IX, Ltd. | 10% | S - Sale | $24.35 | -11.34M | 194.61M | -6% | -$276.07M |
| D | 2022-08-12 | 2022-08-10 | AGL | Schwaneke Jeffrey A. | Dir | A - Grant | $0.00 | +4,009 | 4,009 | New | $0 |
| DM | 2022-08-08 | 2022-08-04+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $4.49 | +16.2K | 18.9K | +587% | +$72.7K |
| DM | 2022-08-08 | 2022-08-04+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $25.03 | -16.2K | 10.9K | -60% | -$405.1K |
| D | 2022-07-25 | 2022-07-21 | AGL | Desai Veeral | Chief Strategy, Dev. Off | M - OptEx | $1.00 | +79.8K | 358.0K | +29% | +$79.8K |
| D | 2022-07-25 | 2022-07-21 | AGL | Desai Veeral | Chief Strategy, Dev. Off | S - Sale+OE | $27.50 | -79.8K | 278.2K | -22% | -$2.19M |
| DM | 2022-07-22 | 2022-07-20+ | AGL | Shaker Benjamin | Chief Markets Off | S - Sale+OE | $27.05 | -100.0K | 27.5K | -78% | -$2.70M |
| D | 2022-07-22 | 2022-07-21 | AGL | Shaker Benjamin | Chief Markets Off | M - OptEx | $1.00 | +49.7K | 77.1K | +181% | +$49.7K |
| DM | 2022-07-19 | 2022-07-15+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $26.41 | -16.2K | 10.9K | -60% | -$427.5K |
| DM | 2022-07-19 | 2022-07-15+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $4.49 | +16.2K | 18.9K | +587% | +$72.7K |
| D | 2022-07-11 | 2022-07-07 | AGL | Desai Veeral | Chief Strategy, Dev. Off | S - Sale+OE | $25.00 | -319.1K | 278.2K | -53% | -$7.98M |
| D | 2022-07-11 | 2022-07-07 | AGL | Desai Veeral | Chief Strategy, Dev. Off | M - OptEx | $1.00 | +319.1K | 597.3K | +115% | +$319.1K |
| DM | 2022-07-06 | 2022-07-01+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $22.84 | -46.6K | 10.9K | -81% | -$1.06M |
| DM | 2022-07-06 | 2022-07-01+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $4.49 | +46.6K | 16.2K | New | +$209.2K |
| D | 2022-06-28 | 2022-06-24 | AGL | Desai Veeral | Chief Strategy, Dev. Off | S - Sale+OE | $22.50 | -106.4K | 278.2K | -28% | -$2.39M |
| D | 2022-06-28 | 2022-06-24 | AGL | Desai Veeral | Chief Strategy, Dev. Off | M - OptEx | $1.00 | +106.4K | 384.6K | +38% | +$106.4K |
| DM | 2022-06-24 | 2022-06-22+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $19.98 | -10.8K | 10.9K | -50% | -$215.6K |
| DM | 2022-06-24 | 2022-06-22+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $4.49 | +10.8K | 16.2K | +198% | +$48.5K |
| DM | 2022-06-13 | 2022-06-09+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $4.49 | +10.8K | 16.2K | +198% | +$48.5K |
| DM | 2022-06-13 | 2022-06-09+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $20.11 | -10.8K | 10.9K | -50% | -$217.1K |
| DM | 2022-06-01 | 2022-05-27+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $4.49 | +10.8K | 16.2K | +198% | +$48.5K |
| DM | 2022-06-01 | 2022-05-27+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $19.67 | -10.8K | 10.9K | -50% | -$212.3K |
| I | 2022-05-27 | 2022-05-25 | AGL | SMITH MICHAEL L | Dir | S - Sale | $19.53 | -145.9K | 4,126 | -97% | -$2.85M |
| DM | 2022-05-12 | 2022-05-10+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $16.21 | -10.8K | 10.9K | -50% | -$174.9K |
| DM | 2022-05-12 | 2022-05-10+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $4.49 | +10.8K | 16.2K | +198% | +$48.5K |
| DM | 2022-04-29 | 2022-04-27+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $4.49 | +10.8K | 16.2K | +198% | +$48.5K |
| DM | 2022-04-29 | 2022-04-27+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $18.49 | -10.8K | 10.9K | -50% | -$199.5K |
| DM | 2022-04-25 | 2022-04-21+ | AGL | Desai Veeral | Chief Strategy, Dev. Off | M - OptEx | $1.00 | +106.4K | 305.0K | +54% | +$106.4K |
| DM | 2022-04-25 | 2022-04-21+ | AGL | Desai Veeral | Chief Strategy, Dev. Off | S - Sale+OE | $20.41 | -106.4K | 288.0K | -27% | -$2.17M |
| DM | 2022-04-21 | 2022-04-19+ | AGL | Desai Veeral | Chief Strategy, Dev. Off | M - OptEx | $1.00 | +212.7K | 384.6K | +124% | +$212.7K |
| DM | 2022-04-21 | 2022-04-19+ | AGL | Desai Veeral | Chief Strategy, Dev. Off | S - Sale+OE | $22.54 | -212.7K | 278.2K | -43% | -$4.79M |
| 2022-04-20 | 2022-04-14 | AGL | Mansukani Sharad | Dir | A - Grant | $0.00 | +6,936 | 1.24M | +0.6% | $0 | |
| 2022-04-20 | 2022-04-14 | AGL | SMITH MICHAEL L | Dir | A - Grant | $0.00 | +6,936 | 159.0K | +5% | $0 | |
| 2022-04-20 | 2022-04-14 | AGL | Gourdine Michelle A | Dir | A - Grant | $0.00 | +6,936 | 18.9K | +58% | $0 | |
| D | 2022-04-20 | 2022-04-14 | AGL | Venkatachaliah Girish | CTO | A - Grant | $0.00 | +10.8K | 16.3K | +199% | $0 |
| DM | 2022-04-20 | 2022-04-18+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $4.49 | +12.8K | 17.1K | +292% | +$57.4K |
| DM | 2022-04-20 | 2022-04-18+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $22.39 | -12.8K | 10.9K | -54% | -$286.0K |
| 2022-04-20 | 2022-04-14 | AGL | Richards Clay | Dir | A - Grant | $0.00 | +6,936 | 35.6K | +24% | $0 | |
| 2022-04-20 | 2022-04-14 | AGL | WILLIAMS RONALD A | Dir | A - Grant | $0.00 | +6,936 | 2.46M | +0.3% | $0 | |
| D | 2022-04-20 | 2022-04-14 | AGL | Sobotka Glenn | CAO | A - Grant | $0.00 | +2,439 | 5,699 | +75% | $0 |
| 2022-04-20 | 2022-04-14 | AGL | Wulf John William | Dir | A - Grant | $0.00 | +6,936 | 123.4K | +6% | $0 | |
| D | 2022-04-20 | 2022-04-14 | AGL | Shaker Benjamin | Chief Markets Off | A - Grant | $0.00 | +13.5K | 77.5K | +21% | $0 |
| D | 2022-04-20 | 2022-04-14 | AGL | Kornitzer Benjamin | Chief Med, Quality Off | A - Grant | $0.00 | +5,419 | 10.9K | +100% | $0 |
| D | 2022-04-20 | 2022-04-14 | AGL | Desai Veeral | Chief Strategy, Dev. Off | A - Grant | $0.00 | +16.3K | 278.2K | +6% | $0 |
| 2022-04-20 | 2022-04-14 | AGL | McLoughlin Karen | Dir | A - Grant | $0.00 | +6,936 | 10.4K | +199% | $0 | |
| D | 2022-04-20 | 2022-04-14 | AGL | Bensley Timothy | CFO | A - Grant | $0.00 | +13.5K | 28.5K | +91% | $0 |
| D | 2022-04-20 | 2022-04-14 | AGL | Sell Steven | CEO, Pres, Dir | A - Grant | $0.00 | +48.8K | 48.8K | New | $0 |
| 2022-04-11 | 2022-04-07 | AGL | Shaker Benjamin | Chief Markets Off | S - Sale | $25.01 | -2,706 | 63.9K | -4% | -$67.7K | |
| D | 2022-03-18 | 2022-03-16 | AGL | Shaker Benjamin | Chief Markets Off | S - Sale+OE | $20.20 | -37.2K | 66.6K | -36% | -$750.5K |
| D | 2022-03-18 | 2022-03-16 | AGL | Shaker Benjamin | Chief Markets Off | M - OptEx | $3.00 | +37.2K | 103.8K | +56% | +$111.5K |
| D | 2022-03-18 | 2022-03-16 | AGL | Desai Veeral | Chief Strategy, Dev. Off | S - Sale+OE | $20.41 | -197.3K | 262.0K | -43% | -$4.03M |
| D | 2022-03-18 | 2022-03-16 | AGL | Desai Veeral | Chief Strategy, Dev. Off | M - OptEx | $1.00 | +197.3K | 459.2K | +75% | +$197.3K |
| M | 2022-03-16 | 2022-03-15 | AGL | Wulf John William | Dir | S - Sale | $19.10 | -30.8K | 136.2K | -18% | -$588.4K |
| DM | 2022-03-16 | 2022-03-14+ | AGL | Shaker Benjamin | Chief Markets Off | S - Sale+OE | $19.85 | -161.0K | 66.6K | -71% | -$3.20M |
| DM | 2022-03-16 | 2022-03-14+ | AGL | Shaker Benjamin | Chief Markets Off | M - OptEx | $3.00 | +161.0K | 146.1K | New | +$483.0K |
| DM | 2022-01-03 | 2021-12-30+ | AGL | Halkias Theodore | Chief Business Off | S - Sale+OE | $27.54 | -13.3K | 5,434 | -71% | -$365.6K |
| DM | 2022-01-03 | 2021-12-30+ | AGL | Halkias Theodore | Chief Business Off | M - OptEx | $1.00 | +13.3K | 6,596 | New | +$13.3K |
| M | 2021-12-30 | 2021-12-28+ | AGL | Shaker Benjamin | Chief Markets Off | S - Sale | $26.68 | -18.7K | 71.3K | -21% | -$499.9K |
| DM | 2021-12-28 | 2021-12-23+ | AGL | Halkias Theodore | Chief Business Off | S - Sale+OE | $27.52 | -26.7K | 5,434 | -83% | -$735.5K |
| DM | 2021-12-28 | 2021-12-23+ | AGL | Halkias Theodore | Chief Business Off | M - OptEx | $1.00 | +26.7K | 26.6K | New | +$26.7K |
| DM | 2021-12-21 | 2021-12-17 | AGL | Danieley Joan | Chief Administrative Off | S - Sale+OE | $22.88 | -21.5K | 5,434 | -80% | -$491.4K |
| D | 2021-12-21 | 2021-12-17 | AGL | Danieley Joan | Chief Administrative Off | M - OptEx | $4.45 | +21.5K | 26.9K | +395% | +$95.6K |
| DM | 2021-12-17 | 2021-12-15+ | AGL | Danieley Joan | Chief Administrative Off | S - Sale+OE | $22.89 | -28.5K | 15.1K | -65% | -$652.8K |
| DM | 2021-12-17 | 2021-12-15+ | AGL | Danieley Joan | Chief Administrative Off | M - OptEx | $4.45 | +28.5K | 30.4K | +1,489% | +$126.9K |
| M | 2021-11-18 | 2021-11-16+ | AGL | Shaker Benjamin | Chief Markets Off | S - Sale | $25.32 | -9,370 | 90.0K | -9% | -$237.2K |
| D | 2021-11-12 | 2021-11-04 | AGL | Sobotka Glenn | CAO | S - Sale+OE | $25.19 | -150.0K | 3,260 | -98% | -$3.78M |
| D | 2021-11-12 | 2021-11-04 | AGL | Sobotka Glenn | CAO | M - OptEx | $7.57 | +150.0K | 153.3K | +4,601% | +$1.14M |
| 2021-11-08 | 2021-11-04 | AGL | Shaker Benjamin | Chief Markets Off | S - Sale | $25.19 | -18.6K | 94.7K | -16% | -$467.5K | |
| 2021-11-04 | 2021-11-03 | AGL | Shaker Benjamin | Chief Markets Off | S - Sale | $25.00 | -300 | 113.3K | -0.3% | -$7,500 | |
| D | 2021-09-15 | 2021-09-14 | AGL | Mansukani Sharad | Dir | M - OptEx | $1.00 | +156.2K | 1.39M | +13% | +$156.2K |
| D | 2021-09-15 | 2021-09-14 | AGL | Mansukani Sharad | Dir | S - Sale+OE | $28.98 | -156.2K | 1.23M | -11% | -$4.53M |
| D | 2021-09-15 | 2021-09-14 | AGL | Sell Steven | CEO, Pres, Dir | M - OptEx | $4.50 | +100.0K | 100.0K | New | +$450.0K |
| D | 2021-09-15 | 2021-09-14 | AGL | Sell Steven | CEO, Pres, Dir | S - Sale+OE | $28.98 | -100.0K | 0 | -100% | -$2.90M |
| 2021-09-15 | 2021-09-14 | AGL | Wulf John William | Dir | S - Sale | $28.98 | -15.3K | 147.3K | -9% | -$444.6K | |
| D | 2021-09-15 | 2021-09-14 | AGL | Halkias Theodore | Chief Business Off | M - OptEx | $1.00 | +58.6K | 64.0K | +1,078% | +$58.6K |
| D | 2021-09-15 | 2021-09-14 | AGL | Halkias Theodore | Chief Business Off | S - Sale+OE | $28.98 | -58.6K | 5,434 | -92% | -$1.70M |
| DI | 2021-09-15 | 2021-09-14 | AGL | Halkias Theodore | Chief Business Off | S - Sale+OE | $28.98 | -100.0K | 0 | -100% | -$2.90M |
| D | 2021-09-15 | 2021-09-14 | AGL | Dombro Lisa | Exper, Innovation Off | M - OptEx | $1.00 | +61.5K | 73.5K | +515% | +$61.5K |
| D | 2021-09-15 | 2021-09-14 | AGL | Dombro Lisa | Exper, Innovation Off | S - Sale+OE | $28.98 | -61.5K | 12.0K | -84% | -$1.78M |
| D | 2021-09-15 | 2021-09-14 | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $4.50 | +11.5K | 16.9K | +211% | +$51.6K |
| D | 2021-09-15 | 2021-09-14 | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $28.98 | -11.5K | 5,434 | -68% | -$332.5K |
| D | 2021-09-15 | 2021-09-14 | AGL | Desai Veeral | Chief Strategy, Dev. Off | M - OptEx | $1.00 | +121.0K | 383.0K | +46% | +$121.0K |
| D | 2021-09-15 | 2021-09-14 | AGL | Desai Veeral | Chief Strategy, Dev. Off | S - Sale+OE | $28.98 | -121.0K | 262.0K | -32% | -$3.51M |
| D | 2021-09-15 | 2021-09-14 | AGL | Shaker Benjamin | Chief Markets Off | M - OptEx | $1.00 | +73.0K | 186.6K | +64% | +$73.0K |
| D | 2021-09-15 | 2021-09-14 | AGL | Shaker Benjamin | Chief Markets Off | S - Sale+OE | $28.98 | -73.0K | 113.6K | -39% | -$2.12M |
| I | 2021-09-14 | 2021-09-14 | AGL | CD&R Vector Holdings, L.P. | 10% | S - Sale | $28.98 | -17.90M | 205.95M | -8% | -$518.87M |
| 2021-09-13 | 2021-09-09 | AGL | SCHNALL RICHARD J | Dir | J - Other | $0.00 | +120.0K | 120.0K | New | $0 | |
| 2021-09-13 | 2021-09-09 | AGL | SCHNALL RICHARD J | Dir | G - Gift | $0.00 | -120.0K | 0 | -100% | $0 | |
| I | 2021-09-13 | 2021-09-09 | AGL | CD&R Investment Associates IX, Ltd. | 10% | J - Other | $0.00 | -865.1K | 223.85M | -0.4% | $0 |
| D | 2021-07-16 | 2021-07-14 | AGL | McLoughlin Karen | Dir | A - Grant | $0.00 | +3,489 | 3,489 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations